![Albert Friesen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Albert Friesen
Directeur Général chez
MEDICURE INC.
Fortune : 2 M $ au 31/05/2026
Profil
Albert D.
Friesen is the founder of Viventia Biotech, Inc. (founded 1995), Medicure, Inc. (founded 1997) where the title held is Chairman, President & Chief Executive Officer, Luminor Medical Technologies, Inc. (founded 1998) where the title held is Chairman, Winnipeg RH Institute Foundation, Inc. (founded 1971) where the title held is President, and Genesys Venture, Inc. (founded 1997) where the title held is President.
Dr. Friesen is also the founder of ABI Biotechnology, Inc.,Genesys Pharma, Inc.,KAM Scientific, Inc.,Industrial Biotechnology Association of Canada..
Dr. Friesen is Chief Executive Officer at CentreStone Ventures, Inc. since 2006.
Dr. Friesen is Chairman, President & Chief Executive Officer at Marsala Biotech Inc. Dr. Friesen is Co-Chairman at Manitoba Innovation Council.
Dr. Friesen is Chairman at Waverley Pharma, Inc. since 2016.
Dr. Friesen is Chairman & President at GVI Clinical Development Solutions, Inc. Dr. Friesen is Director at Mylan API, Inc. Dr. Friesen is Director at Magellan Biotech, Inc. Dr. Friesen is Director at Canada Foundation for Innovation since 2010.
Dr. Friesen is Director at Sensible Medical Innovations Ltd. since 2019.
Dr. Friesen was Chief Executive Officer & Director at Big Sky Petroleum Corp.
from 2006 to 2008.
Dr. Friesen was CEO, Secretary & Non-Independent Director at Buffalo Capital, Inc. Dr. Friesen was Chairman at Kane Biotech, Inc. from 2001 to 2011.
Dr. Friesen was Director at DiaMedica Therapeutics, Inc. from 2007 to 2008.
Dr. Friesen was Director at MEDA Investments, Inc. from 2000 to 2012.
Dr. Friesen was Director at Waverley Pharma, Inc. Dr. Friesen was Member-Industrial Advisory Committee at Biotechnology Research Corp.
Dr. Friesen earned a doctorate from the University of Manitoba.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
MEDICURE INC. 24,94 % | 22/06/2026 | 2 602 827 ( 24,94 % ) | 2 M $ | 31/05/2026 |
WAVERLEY PHARMA, INC. 74,61 % | 05/05/2025 | 40 292 000 ( 74,61 % ) | 282 044 $ | 31/05/2026 |
Postes actifs de Albert Friesen
| Sociétés | Poste | Début |
|---|---|---|
| MEDICURE INC. | Directeur Général | 15/09/1997 |
| WAVERLEY PHARMA INC. | Président | 14/12/2016 |
CentreStone Ventures, Inc.
 CentreStone Ventures, Inc. Investment ManagersFinance CentreStone is an active manager which invests in life sciences companies located in western Canada and the US Midwest region. It participates in early stage capital requirements. | Directeur Général | 01/01/2006 |
Sensible Medical Innovations Ltd.
 Sensible Medical Innovations Ltd. Medical SpecialtiesHealth Technology Develops pulmonary edema screening devices | Directeur/Membre du Conseil | 29/01/2019 |
Mylan API, Inc.
 Mylan API, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Marsala Biotech Inc
 Marsala Biotech Inc BiotechnologyHealth Technology Engages in discovery and development of drugs for cancer treatment | Directeur Général | - |
Manitoba Innovation Council | Président | 20/05/2011 |
Canada Foundation For Innovation
 Canada Foundation For Innovation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | 16/02/2010 |
Magellan Biotech, Inc.
 Magellan Biotech, Inc. Financial ConglomeratesFinance Provides private equity services to biotechnology companies | Directeur/Membre du Conseil | 25/11/2009 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Albert Friesen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Albert Friesen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Medicure, Inc.
 Medicure, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research, development and commercialization & marketing of human therapeutics products | Health Technology |
Viventia Biotech, Inc.
 Viventia Biotech, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and commercializes monoclonal antibody products | Health Technology |
Luminor Medical Technologies, Inc.
 Luminor Medical Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology research and development services | Commercial Services |
Kane Biotech, Inc.
 Kane Biotech, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that manufactures animal health oral care products | Commercial Services |
DiaMedica Therapeutics, Inc.
 DiaMedica Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of therapeutic treatments from novel recombinant proteins | Health Technology |
Mylan API, Inc.
Mylan API, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Magellan Biotech, Inc.
Magellan Biotech, Inc. Financial ConglomeratesFinance Provides private equity services to biotechnology companies | Finance |
University of Manitoba
 University of Manitoba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CentreStone Ventures, Inc.
CentreStone Ventures, Inc. Investment ManagersFinance CentreStone is an active manager which invests in life sciences companies located in western Canada and the US Midwest region. It participates in early stage capital requirements. | Finance |
Biotechnology Research Corp.
 Biotechnology Research Corp. Miscellaneous Commercial ServicesCommercial Services Engages in biotechnology research and development | Commercial Services |
Industrial Biotechnology Association of Canada | |
Genesys Venture, Inc.
 Genesys Venture, Inc. Financial ConglomeratesFinance Operates as an investment firm which specializes in incubation | Finance |
Canada Foundation For Innovation
Canada Foundation For Innovation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Winnipeg RH Institute Foundation, Inc.
 Winnipeg RH Institute Foundation, Inc. The Winnipeg Rh Institute Foundation is a private, non-profit organization based in Winnipeg, Canada. The foundation supports research and scholarship in various fields, with a primary focus on improving child health. It collaborates with partner institutions such as the University of Manitoba, the Children Hospital Research Institute of Manitoba (Chi), the University, and the Winnipeg Art Gallery to provide funding for rising researchers, scholars, and artists. The foundation's primary mission is to sponsor awards, scholarships, conferences, and research projects, while its secondary mission is supporting the humanities through an annual grant to the Winnipeg Arts Gallery. The founders of the foundation developed a vaccine that has saved countless lives worldwide. The board consists of three directors and 12 members, each elected by current members and serving on a volunteer basis. | |
ABI Biotechnology, Inc. | |
Genesys Pharma, Inc. | |
KAM Scientific, Inc.
 KAM Scientific, Inc. Chemicals: AgriculturalProcess Industries Manufactures and distributes microbial disinfectant spray solutions for laboratories, hospitals, dental offices and medical clinics | Process Industries |
MEDA Investments, Inc.
 MEDA Investments, Inc. Investment ManagersFinance Alternative investment manager | Finance |
Sensible Medical Innovations Ltd.
Sensible Medical Innovations Ltd. Medical SpecialtiesHealth Technology Develops pulmonary edema screening devices | Health Technology |
Manitoba Innovation Council | |
Big Sky Petroleum Corp.
 Big Sky Petroleum Corp. Oil & Gas ProductionEnergy Minerals Explores for oil and natural gas | Energy Minerals |
GVI Clinical Development Solutions, Inc.
 GVI Clinical Development Solutions, Inc. Miscellaneous Commercial ServicesCommercial Services Provides business consultancy services | Commercial Services |
Buffalo Capital, Inc.
 Buffalo Capital, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Marsala Biotech Inc
Marsala Biotech Inc BiotechnologyHealth Technology Engages in discovery and development of drugs for cancer treatment | Health Technology |
Waverley Pharma, Inc. /Old/
 Waverley Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Engages in design and development molecule drugs | Health Technology |
Waverley Pharma, Inc.
 Waverley Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
